Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Prostate Cancer Metastatic × Midazolam × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 3 Prostate Cancer Metastatic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain, Postoperative 1 Neoplasm, Residual 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 KRAS p.G12C Mutant Advanced Solid Tumors 1 Hematologic Neoplasms 1

Interventions

gallium 68 PSMA-11 1 Radiosurgery 1 Midazolam 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03436485 2025-07-22

CYPIDES

Orion Corporation, Orion Pharma

Phase 1/2 Active not recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡